PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
 
Vector Borne Zoonotic Dis. Feb 2010; 10(1): 85–92.
PMCID: PMC2945867
Recent Findings Regarding Maintenance of Enzootic Variants of Yersinia pestis in Sylvatic Reservoirs and Their Significance in the Evolution of Epidemic Plague
Scott W. Beardencorresponding author1 and Robert R. Brubaker2
1Division of Vector-Borne Infectious Diseases, Bacterial Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, Colorado.
2Department of Microbiology, The University of Chicago, Chicago, Illinois.
corresponding authorCorresponding author.
Address correspondence to: Scott W. Bearden, Division of Vector-Borne Infectious Diseases, Bacterial Diseases Branch, Centers for Disease Control and Prevention, 3150 Rampart Road, Foothills Campus, Fort Collins, CO 80521. E-mail:zyv3/at/cdc.gov
Despite the widespread presence of bubonic plague in sylvatic reservoirs throughout the world, the causative agent (Yersinia pestis) evolved in its present form within the last 20,000 years from enteropathogenic Yersinia pseudotuberculosis. Comparison of the genomes from the two species revealed that Y. pestis possesses only a few unique plasmid-encoded genes that contribute to acute disease, whereas this organism has lost about 13% of the chromosomal genes that remain active in Y. pseudotuberculosis. These losses reflect readily detectable additions, deletions, transpositions, inversions, and acquisition of about 70 insertion sequence (IS) inserts, none of which are likely to promote increased virulence. In contrast, major enzymes of intermediary metabolism, including glucose 6-phosphate dehydrogenase (Zwf ) and aspartase, are present but not catalytically functional due to the presence of missense mutations. The latter are generally not detectable by the technology of bioinformatics and, in the case of Y. pestis, result in radical changes in the metabolic flow of carbon. As an important consequence, plague bacilli exhibit a stringent low-calcium response characterized by conversion of L-glutamate (and metabolically related amino acids) to L-aspartate with secretion of the latter into supernatant fluid at 37°C in culture media containing Na+ but lacking added Ca2+. This phenomenon also occurs in vivo and likely adversely affects the bioenergetics of host amino acid pools. Curiously, aspartase is functional in all tested enzootic (pestoides) strains of Y. pestis. These isolates are typically restricted to the ancient plague reservoirs of Central Asia and Africa and are fully virulent in members of the rodent Superfamily Muroidea but avirulent in guinea pigs and man. The implications of these findings for the distribution and ecology of Y. pestis could be significant.
Key Words: Aspartase, Glucose 6-phosphate dehydrogenase, Intermediary metabolism, Pestoides
Approximately 200 million years ago the yersiniae line carrying the progenitor low Ca2+-response (LCR) virulence plasmid, now termed pCD (calcium dependence) in Yersinia pestis (Ferber and Brubaker 1981), diverged, leading to the emergence of modern Yersinia enterocolitica and Y. pseudotuberculosis (Achtman et al. 1999). These organisms retain slightly different functional forms of this ~70-kb plasmid (Hu et al. 1998), where it is designated pYV (Yersinia Virulence) (Zink et al. 1980), and exhibit both modest gains and losses of chromosomal genes (Chain et al. 2004, 2006, Thomson et al. 2006). Important additions to Y. pseudotuberculosis that occurred during this long period of evolution include the ability to synthesize and incorporate 2,6-dideoxy-hexoses (not present in Y. enterocolitica) into lipopolysaccharide O-groups (Davies 1961), express a catalase-peroxidase termed KatY (Garcia et al. 1999), and colonize regional lymphatic tissue (Avtsyn et al. 1990) as opposed to Y. enterocolitica, which more commonly promotes direct gastrointestinal disease (Bottone 1997). Nevertheless, both of these species remain enteropathogens and, except for the new world serogroup O:8 isolates of Y. enterocolitica (Carter and Collins 1974), seldom cause systemic disease in noncompromised human hosts.
In contrast, Y. pestis (the etiological agent of bubonic plague), which evolved from a serotype O:1b strain of Y. pseudotuberculosis (Skurnik et al. 2000) within the last 5000–15,000 years (Achtman et al. 1999), arguably causes the most severe epidemic disease known to human (Pollitzer 1954, Orient 2004, Kelly 2005). This eyeblink of geological time is far too short to accommodate de novo gene evolution or significant modification and regulation of preexisting genes capable of causing acute infection. However, salient new genetic information was acquired during this period by lateral transfer of two unique plasmids of ~10 and ~110 kb termed pPCP (pesticin coagulase plasminogen activator) and pMT (murine toxin), respectively (Ferber and Brubaker 1981). The plasminogen activator of the plague bacillus (Beesley et al. 1967, Sodeinde et al. 1992, Lähteenmäki et al. 1998, Kukkonen et al. 2004) is encoded by pPCP (Ferber and Brubaker 1981) and fraction 1 antigen (F1) of typically encapsulated Y. pestis (Baker et al. 1952) and murine toxin, a phospholipase D (Rudolph et al. 1999), are encoded by pMT (Protsenko et al. 1983, Kutyrev et al. 1986). Nevertheless, these Y. pestis–specific determinants are not always essential for acute disease as judged by the observation that transformation of pPCP into Y. pseudotuberculosis did not significantly increase virulence in mice (Kutyrev et al. 1999), and the absence of this plasmid in certain enzootic isolates of Y. pestis (described below) did not hinder tissue invasiveness (Worsham and Roy 2003). Similarly, F1 is not required for virulence in mice (Burrows 1957), and a fatal human case of plague was caused by an F1-deficient mutant (Winter et al. 1960). These findings strongly suggest that other factors contribute to the acute nature of plague. This paper discusses recent data regarding the importance of the absence of an active aspartase enzyme for the virulence of Y. pestis in mammalian hosts and its potential implications for the distribution and ecology of plague.
Chromosomal degeneration
An attractive alternative explanation for the severity of plague is the possibility that invasiveness is a function of genetic loss. The major phenotypic differences between Y. pestis and Y. pseudotuberculosis are summarized in Table 1. These include recognition that plague bacilli typically exhibit a longer doubling time than cells of the enteropathogenic yersiniae, especially at host temperature (Brubaker 1972, Perry and Fetherston 1997). This reduced rate of growth is correlated with a requirement for CO2 that is not essential but, if supplied, shortens the division time of Y. pestis to that of Y. pseudotuberculosis provided that other essential nutrients are present (Delwiche et al. 1959, Surgalla et al. 1964). Early studies demonstrated that CO2 is normally fixed by Y. pestis into phosphoenolpyruvate (via phosphoenolpyruvate carboxykinase and an irreversible phosphoenolpyruvate carboxylase) to form oxaloacetate (Baugh et al. 1964) as is typical of many bacterial species. Although this approach did not resolve the basis for the stimulatory role of CO2 for Y. pestis, it did implicate oxalacetate, the immediate precursor of L-aspartic acid, as a critical intermediate. Results of subsequent work (Dreyfus and Brubaker 1978) showed that classical strains of Y. pestis lacked the common prokaryotic enzyme aspartate ammonia-lyase or aspartase (AspA) that converts L-aspartate into fumarate, an intermediate of the tricarboxylic acid cycle. Unrelated parallel work (Mortlock 1962, Mortlock and Brubaker 1962) undertaken on hexose metabolism also demonstrated the absence in typical plague bacilli of glucose 6-phosphate dehydrogenase (Zwf ), the initial enzyme of the pentose phosphate pathway (required for production of pentose for nucleic acid synthesis). These two genetic lesions promote a significant lack of fitness, at least in vitro, and likely account in full for the fastidious nature of Y. pestis as opposed to Y. pseudotuberculosis and Y. enterocolitica (Fowler and Brubaker 1994, Brubaker 2005, 2007, Viola et al. 2008).
Table 1.
Table 1.
Phenotypic Distinctions Between Typical Strains of Yersinia pestis and Yersinia pseudotuberculosis (Brubaker 2004)
Comparative annotation of the genomes of Y. pestis (Parkhill et al. 2001, Deng et al. 2002, Zhou et al. 2004a) and Y. pseudotuberculosis (Chain et al. 2004, 2006) revealed that plague bacilli have lost about 13% of all genes that remain functional in Y. pseudotuberculosis. This gene reduction reflects the consequences of chromosomal inversion, transposition, deletion, insertion of ~70 IS elements, and various mechanisms causing altered reading frames. These events account for known alterations between pCD and pYV (Hu et al. 1998), loss mutations promoting a reduced inflammatory response (Kukkonen et al. 2001, Kawahara et al. 2002), and the differences accounting for phenotypic distinctions in nutritional requirements, carbohydrate fermentation, and other biochemical properties (Brubaker 2004). The comparison did not, however, accommodate the critical absence of functional aspA or zwf, and subsequent effort demonstrated that these losses were caused by altered single DNA base pairs causing missense mutations.
Loss of AspA and Zwf in Y. pestis via missense mutation
A single base transition (T · A  C · G) at amino acid position 155 causes replacement of serine in the active Zwf of Y. pseudotuberculosis with proline in the inactive enzyme of typical Y. pestis (Chain et al. 2004, 2006). It is well established that proline causes distortion of secondary structure, and thus loss of enzyme activity after its introduction into a given enzyme is not surprising. In contrast, inactivity of AspA reflects a single base transversion (G · C  T · A) at amino acid position 363, where valine is replaced in the active enzyme of Y. pseudotuberculosis by the structurally similar, but inactive, leucine of typical isolates of Y. pestis (Chain et al. 2004, 2006). Skepticism regarding the possibility that substitution of one aliphatic amino acid by another solely accounts for loss of catalytic ability was eliminated by demonstrating that restoration of the active valine at position 363 of the AspA of Y. pestis restored full enzymatic activity. This seemingly innocuous change, which significantly reduces turnover (kcat) but not substrate binding (Km), may cause alteration in positioning of the adjacent catalytic residues Glu334 and Gln191 (Viola et al. 2008).
Influence of AspA and Zwf on the low calcium response
As noted above, the LCR is mediated by pCD/pYV. This phenotype is defined as the ability to either initiate vegetative growth at 37°C in vitro in the presence of ~2.5 mM Ca2+ without upregulation of a pCD/pYV-encoded type 3 secretion system (T3SS) or to undergo bacteriostasis with full induction of this T3SS. The LCR is especially stringent in typical strains of Y. pestis, and restricted growth in Ca2+-deficient medium is characterized by accumulation of L-aspartic acid in spent culture medium (Dreyfus and Brubaker 1978, Brubaker 2005). It is highly likely that this lost aspartic acid accounts for the prompt shutoff of growth observed for cells of Y. pestis after shift from 26°C to 37°C in Ca2+-deficient medium (Brubaker 2007) since this form of bacteriostasis occurs as a consequence of reduced adenylate energy charge (Zahorchak et al. 1979). Another variable that influences the nutritional response of typical plague bacilli to Ca2+ is the presence of Na+, which may serve as a porter for the exit of aspartic acid at 37°C. Indeed, at slightly acidic pH the organisms exhibit normal full-scale growth if both Na+ and Ca2+ are omitted from the culture medium. Na+ did not, however, significantly modify the parallel upregulation of the attendant T3SS known to be functional in Ca2+-starved cells grown at 37°C (Brubaker 2007). In summary, these findings suggest that the abrupt bacteriostasis observed for typical Ca2+-starved cells of Y. pestis is caused by loss of metabolic carbon released in the form of aspartic acid by at least one Na+-driven export reaction.
As already noted, Zwf initiates the synthesis of ribose from hexose via the pentose phosphate pathway. This reaction probably has little importance in cells of Y. pestis, which typically reside within a closed flea–host cycle where exogenous pentose is readily available; the organisms can also generate ribose from 3-carbon fragments via transketolase–transaldolase rearrangement (Mortlock 1962). However, nicotinamide adenine dinucleotide phosphate (NADPH) is an important secondary product of Zwf that must be generated by alternative means by Y. pestis grown on hexose. Plague bacilli cultivated at 37°C in a Ca2+-deficient chemically defined medium containing glucose undergo marked lysis (Brownlow and Wessman 1960); thus, Zwf-deficiency may also modulate the LCR in these organisms. This phenomenon, of course, is distinct from the typical bacteriostasis with retention of viability that occurs in Ca2+-deficient medium containing Na+, at neutral pH.
Enzootic strains of Y. pestis
Available evidence indicates that the transmission of plague in sylvatic reservoirs is almost exclusively undertaken by fleabite. Reliance upon this method of transfer depends upon a sufficient host bacteremia to ensure infection of the flea vector (Engelthaler et al. 2000, Eisen et al. 2006) and the ability of Y. pestis to kill their current host, thereby assuring that infectious fleas disseminate in search of new hosts. Mortality therefore became an essential part of the life cycle of Y. pestis, and selective pressure caused by this necessity has obviously directed the further evolution of acute disease. As a consequence of this process, plague bacilli became efficient pathogens and have now disseminated from ancestral foci in Central Asia and perhaps Africa to reservoirs throughout the world where they cause lethal disease in many animal species, including humans (Suntsov and Suntsova 2008). The virulence of these potential “epidemic” isolates contrasts markedly with “enzootic” strains of Y. pestis (also termed “pestoides” variants) that remain contained within their original reservoirs (Martinevskii 1969, Anisimov et al. 2004). Enzootic isolates are now classified according to subspecies designation altaica, caucasica, hissarica, ulegeica, and talassica (Anisimov et al. 2004). With the exception of caucasica isolates (which lack pPCP) these enzootic strains possess all known virulence factors of epidemic isolates, and commonly retain the normal ability of Y. pseudotuberculosis to ferment the sugars rhamnose and melibiose. Curiously, they are attenuated in many mammalian species, including guinea pigs and primates, but remain virulent in members of the rodent Superfamily Muroidea and in nature have only been recovered from these rodents or their fleas (Martinevskii 1969, Anisimov et al. 2004). Further study of enzootic variants has recently shown that they sometimes express catalytically active Zwf and always exhibit functional AspA (Bearden et al. 2008).
AspA and Zwf in enzootic Y. pestis
A comparison of 10 enzootic isolates of Y. pestis with their epidemic counterparts (Bearden et al. 2008) demonstrated that three of the former expressed functional Zwf associated with retention of serine at amino acid position 155 (Table 2). These strains were the Russian pestoides E, F, and G strains, all of subspecies caucasica, that also exhibit other primitive traits, including the absence of pPCP and attendant plasminogen activator. All tested enzootic isolates produced biologically active AspA although its specific activity exhibited significant variation depending upon the amino acid present at amino acid position 363. The value of aspartase activity was essentially identical to that of Y. pseudotuberculosis when valine was retained at this position (the Russian pestoides A, B, C, and D strains) or when serine was substituted for valine (the Russian pestoides E, F, G, and I strains). Curiously, the enzootic Angola and A16 strains from Africa contained phenylalanine at this position and exhibited significantly reduced but nevertheless significant activity (Table 2). Further, cells of the attenuated enzootic microtus biovar isolate from China (Fan et al. 1995) encode valine at amino acid position 363 of AspA (Zhou et al. 2004b) and should therefore exhibit enzymatic activity. These findings indicate that synthesis of enzymatically active AspA is a biomarker of attenuation in nonmuroid hosts. Further, the observations have obvious significance with respect to expression of acute disease as well as the evolution and potential spread of epidemic isolates.
Table 2.
Table 2.
Codons for Amino Acids at Position 155 of Glucose 6-Phosphate Dehydrogenase (Zwf ) and Position 363 of Aspartase and Corresponding Specific Activitiesa in Dialyzed Cell-Free Extracts Prepared from Yersiniaeb Expressing These Enzymes (Bearden et (more ...)
Acute disease and deficiency of AspA
Formal proof that active AspA in Y. pestis promotes attenuation will be, of course, dependent upon experiments involving salient gene exchange. Nevertheless, this correlation is presently absolute; thus, it is appropriate to consider possible mechanisms where genetic loss of AspA could enhance the ability to cause acute disease. The physiological role of AspA is to assure return of the four carbons comprising the backbone of aspartic acid (generated via catabolic transamination of L-glutamate with oxalacetate) into the tricarboxylic acid cycle in the form of fumarate (Halpern and Umbarger 1960). This mechanism assures the efficient flow of carbon by preventing accumulation of catabolic end-products other than CO2 and NH4+ (Table 3). As such, nearly ubiquitous AspA assures that a large number of saprophytic bacteria capable of its expression remain capable of efficient metabolism during growth in austere environments. Plague bacilli, however, typically reside in the closed, highly enriched, and protected environments of the host and flea vector where efficient processes of catabolism are unnecessary. Indeed, examination of mRNA transcribed during steady-state growth at 37°C showed that the catabolic process used by Y. pestis in the host is inefficiently regulated and largely wasteful if not prodigal (Motin et al. 2004). Accordingly, plague bacilli may have no need for the tempering influence of AspA on catabolism but rather proceed to consume and destroy host nutrient pools quickly and with abandon.
Table 3.
Table 3.
Enzymatic Reactions Involved in the Catabolism of L-Glutamate by Aspartase-Positive Yersinia pseudotuberculosis (and Enzootic Strains of Yersinia pestis) and Epidemic Aspartase-Negative Isolates of Y. pestis
The ability of epidemic strains of Y. pestis to accumulate metabolic aspartate may have an additional sinister effect. Amino acids other than L-glutamate also serve as a source of carbon for synthesis of aspartate during starvation for Ca2+. These include metabolically linked L-proline as well as L-asparagine, which is in equilibrium with L-glutamine in the host (Soupart 1962) and rapidly and stoichiometrically undergoes conversion to L-aspartate in vitro (Dreyfus and Brubaker 1978). This event would be highly deleterious to the host should it occur in vivo because the largest amino acid components of mammalian serum and cytoplasm are L-glutamate, L-glutamine, and L-asparagine, whereas L-aspartate comprises the smallest (Soupart 1962). Reversal of this ratio by secretion of metabolic aspartate would seriously affect the metabolic equilibrium and bioenergetics of these pools by the host, an event that might be especially deleterious during the terminal stages of infection. In this context, it may be significant that only a few other aerobic bacteria also lack AspA, but this group includes Mycobacterium tuberculosis (Fleischmann et al. 2002), Francisella tularensis (Larsson et al. 2005), and rickettsiae (Andersson et al. 1998). The latter, like epidemic isolates of Y. pestis, also convert exogenous L-glutamate to L-aspartate, which is released into the culture medium (Bovarnick and Miller 1950).
Expression of AspA by and attenuation of enzootic isolates of Y. pestis still renders these strains fully capable of killing muroid rodents, suggesting that they possess some factor (other than that associated with AspA-deficiency) that contributes to this process. A likely possibility is pMT-encoded murine toxin, which is highly lethal in muroids but not essential for virulence of epidemic strains of Y. pestis in mice, although it does appear to be important for survival of plague bacteria in the midgut of the flea vector (Hinnebusch et al. 2000, Hinnebusch et al. 2002). It seems possible that the raison d'être for AspA in enzootic strains of Y. pestis is no more than that in the enteropathogenic yersiniae where it facilitates efficient amino acid catabolism in minimal environments. These strains are often, but not always limited, to grasslands and similar habitats containing burrowing muroid rodents (e.g., gerbils and voles), and their maintenance may depend in part on survival in soils including those surrounding decomposed host carcasses (Ayyadurai et al. 2008, Eisen et al. 2008).
Finally, the paucity of available enzootic isolates underscores the importance of further studies examining the mechanisms for the ecological persistence of these genetically and phenotypically diverse strains in sylvatic foci. Moreover, the behavior of these strains in fleas, particularly as it relates to plague virulence, pathogenesis, host immunity, and focal distribution, warrants further investigation. Needless to say, construction and virulence testing of AspA-positive epidemic isolates and murine toxin–deficient enzootic isolates should resolve many of the issues raised in this review.
Acknowledgments
This work was sponsored by the NIH/NIAID (National Institutes of Health/National Institute of Allergy and Infectious Diseases) Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. R.R.B wishes to acknowledge membership within and support from the Region V “Great Lakes” RCE (NIH Award 1-U54-AI-057153).
Disclosure Statement
No competing financial interests exist.
  • Achtman M. Zurth K. Morelli G. Torrea G, et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA. 1999;96:14043–14048. [PubMed]
  • Andersson SG. Zomorodipour A. Andersson JO. Sicheritz-Ponten T, et al. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature. 1998;396:133–140. [PubMed]
  • Anisimov A. Lindler L. Pier G. Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev. 2004;17:434–464. [PMC free article] [PubMed]
  • Avtsyn AP. Isachkova LM. Zhavoronkov AA. Somov GP. Makhnev MV. The basic features of the pathogenesis of pseudotuberculosis (yersiniosis) Arkh Patol. 1990;52:3–7. [PubMed]
  • Ayyadurai S. Houhamdi L. Lepidi H. Nappez C, et al. Long-term persistence of virulent Yersinia pestis in soil. Microbiology. 2008;154:2865–2871. [PubMed]
  • Baker EE. Somer H. Foster LW. Meyer E. Meyer KF. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol. 1952;68:131–145. [PubMed]
  • Baugh CL. Lanham JW. Surgalla M. Effects of bicarbonate on growth of Pasteurella pestis. II. Carbon dioxide fixation into oxalacetate by cell-free extracts. J Bacteriol. 1964;88:1394–1398. [PMC free article] [PubMed]
  • Bearden SW. Sexton C. Pare J. Fowler JM, et al. Attenuated enzootic (pestoides) isolates of Yersinia pestis express active aspartase. Microbiology. 2009;155:198–209. [PubMed]
  • Beesley ED. Brubaker RR. Janssen WA. Surgalla MJ. Pesticins. III. Expression of coagulase and mechanism of fibrinolysis. J Bacteriol. 1967;94:19–26. [PMC free article] [PubMed]
  • Ben-Gurion R. Shafferman A. Essential virulence determinants of different Yersinia species are carried on a common plasmid. Plasmid. 1981;5:183–187. [PubMed]
  • Bottone XJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev. 1997;10:257–276. [PMC free article] [PubMed]
  • Bovarnick MR. Miller JC. Oxidation and transamination of glutamate by typhus rickettsiae. J Biol Chem. 1950;184:661–676. [PubMed]
  • Brownlow WJ. Wessman GE. Nutrition of Pasteurella pestis in chemically defined media at temperatures of 36 to 38 C. J Bacteriol. 1960;79:288–304. [PMC free article] [PubMed]
  • Brubaker R. The recent emergence of plague: a process of felonious evolution. Microb Ecol. 2004;47:293–299. [PubMed]
  • Brubaker RR. Yersinia: biochemistry and genetics of virulence. Curr Top Microbiol. 1972;57:111–158. [PubMed]
  • Brubaker RR. Influence of Na+, dicarboxylic amino acids, and pH in modulating the low-calcium response of Yersinia pestis. Infect Immun. 2005;73:4743–4752. [PMC free article] [PubMed]
  • Brubaker RR. Intermediary metabolism, Na+, the low calcium-response, and acute disease. In: Perry RD, editor. The Genus Yersinia: From Genomics to Function. New York: Springer; 2007. pp. 116–129.
  • Brubaker RR. Sulen AJ. Mutations influencing the assimilation of nitrogen by Yersinia pestis. Infect Immun. 1971;3:580–588. [PMC free article] [PubMed]
  • Burrows TW. Virulence of Pasteurella pestis. Nature. 1957;179:1246–1247. [PubMed]
  • Burrows TW. Gillett WA. The nutritional requirements of some Pasteurella species. J Gen Microbiol. 1966;45:333–345. [PubMed]
  • Carter PB. Collins FM. Experimental Yersinia enterocolitica infection in mice: kinetics of growth. Infect Immun. 1974;9:851–857. [PMC free article] [PubMed]
  • Chain P. Carniel E. Larimer FW. Lamerdin J, et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci USA. 2004;101:13826–13831. [PubMed]
  • Chain PSG. Hu P. Malfatti SA. Radnedge L, et al. Complete genome sequence of Yersinia pestis strains Antiqua and Nepal516: evidence of gene reduction in an emerging pathogen. J Bacteriol. 2006;188:4453–4463. [PMC free article] [PubMed]
  • Davies DAL. Dideoxysugars of Pasteurella pseudotuberculosis-specific polysaccharides, and the occurrence of ascarylose. Nature. 1961;191:43–44. [PubMed]
  • Delwiche EA. Fukui GM. Andrews AW. Surgalla MJ. Environmental conditions affecting the population dynamics and the retention of virulence of Pasteurella pestis: the role of carbon dioxide. J Bacteriol. 1959;77:355–380. [PMC free article] [PubMed]
  • Deng W. Burland V. Plunkett GI. Boutin A, et al. Genome sequence of Y. pestis KIM. J Bacteriol. 2002;104:4601–4611. [PMC free article] [PubMed]
  • Dreyfus LA. Brubaker RR. Consequences of aspartase deficiency in Yersinia pestis. J Bacteriol. 1978;136:757–764. [PMC free article] [PubMed]
  • Eisen RJ. Bearden SW. Wilder AP. Montenieri JA, et al. Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics. Proc Natl Acad Sci USA. 2006;103:15380–15385. [PubMed]
  • Eisen RJ. Petersen JM. Higgins CL. Wong D, et al. Persistence of Yersinia pestis in soil under natural conditions. Emerg Infect Dis. 2008;14:941–943. [PMC free article] [PubMed]
  • Engelthaler DM. Hinnebusch BJ. Rittner CM. Gage KL. Quantitative competitive PCR as a technique for exploring flea-Yersina pestis dynamics. Am J Trop Med Hyg. 2000;62:552–560. [PubMed]
  • Englesberg E. Mutation of rhamnose utilization in Pasteurella pestis. J Bacteriol. 1957;73:641–647. [PMC free article] [PubMed]
  • Englesberg E. Ingraham L. Meiotrophic mutants of Pasteurella pestis and their use in elucidation of nutritional requirements. Proc Natl Acad Sci USA. 1957;43:369–372. [PubMed]
  • Fan Z. Luo Y. Wang S. Jin L, et al. Microtus brandti plague in the Xilin Gol Grassland was inoffensive to humans. Chin J Control Endem Dis. 1995;10:56. –57 (in Chinese).
  • Ferber DM. Brubaker RR. Plasmids in Yersinia pestis. Infect Immun. 1981;31:839–841. [PMC free article] [PubMed]
  • Fleischmann RD. Alland D. Eisen JA. Carpenter L, et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002;184:5479–5490. [PMC free article] [PubMed]
  • Fowler JM. Brubaker RR. Physiological basis of the low calcium response in Yersinia pestis. Infect Immun. 1994;62:5234–5241. [PMC free article] [PubMed]
  • Garcia E. Nedialkov YA. Elliott J. Motin VL. Brubaker RR. Molecular characterization of KatY (antigen 5), a thermoregulated chromosomally encoded catalase-peroxidase of Yersinia pestis. J Bacteriol. 1999;181:3114–3122. [PMC free article] [PubMed]
  • Halpern YS. Umbarger HE. Conversion of ammonia to amino groups in Escherichia coli K-12 mutants. J Bacteriol. 1960;80:285–288. [PMC free article] [PubMed]
  • Hare JM. McDonough KA. High-frequency RecA-dependent and -independent mechanisms of Congo red binding mutations in Yersinia pestis. J Bacteriol. 1999;181:4896–4904. [PMC free article] [PubMed]
  • Hinnebusch J. Cherepanov P. Du Y. Rudolph A, et al. Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice. Int J Med Microbiol. 2000;290:483–487. [PubMed]
  • Hinnebusch BJ. Rudolph AE. Cherepanov P. Dixon JE, et al. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science. 2002;296:733–735. [PubMed]
  • Hu P. Elliott J. McCready P. Skowronski E, et al. Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol. 1998;180:5192–5202. [PMC free article] [PubMed]
  • Jones HA. Lillard JW. Perry RD. HmsT, a protein essential for expression of the haemin storage (Hms+) phenotype of Yersinia pestis. Microbiology. 1999;145:2117–2128. [PubMed]
  • Kawahara K. Tsukano H. Watanabe H. Lindler B. Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun. 2002;70:4092–4098. [PMC free article] [PubMed]
  • Kelly J. The Great Mortality: An Intimate History of the Black Death, the Most Devastatingplague of All Time. New York: Harper Collins Publishers; 2005.
  • Kukkonen M. Lähteenmäki K. Suomalainen M. Kalkkinen N, et al. Protein regions important for plasminogen activation and inactivation of α2-antiplasmin in the surface protease Pla of Yersinia pestis. Mol Microbiol. 2001;40:1–16. [PubMed]
  • Kukkonen M. Suomalainen M. Kyllonen P. Lahteenmaki K, et al. Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica. Mol Microbiol. 2004;51:215–225. [PubMed]
  • Kutyrev V. Mehigh RJ. Motin VL. Pokrovskaya MS, et al. Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli. Infect Immun. 1999;67:1359–1367. [PMC free article] [PubMed]
  • Kutyrev VV. Popov YA. Protsenko OA. Pathogenicity plasmids of the plague microbe (Yersinia pestis) Mol Gen Mikrobiol Virusol. 1986;6:3–11. [PubMed]
  • Lähteenmäki K. Virkola R. Sarén A. Emödy E. Korhonen TK. Expression of the plasminogen activator Pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect Immun. 1998;e66:5755–5762. [PMC free article] [PubMed]
  • Larsson P. Oyston PC. Chain P. Chu MC, et al. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet. 2005;37:153–159. [PubMed]
  • Martinevskii IL. Biology and Genetic Features of Plague and Plague-Related Microbes. Moscow: Meditsina Press; 1969.
  • Mortlock RP. Gluconate metabolism of Pasteurella pestis. J Bacteriol. 1962;84:53–59. [PMC free article] [PubMed]
  • Mortlock RP. Brubaker RR. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities of Pasteurella pestis and Pasteurella pseudotuberculosis. J Bacteriol. 1962;84:1122–1123. [PMC free article] [PubMed]
  • Motin VL. Georgescu AM. Fitch JP. Gu PP, et al. Temporal global changes in gene expression during temperature transition in Yersinia pestis. J Bacteriol. 2004;186:6298–6305. [PMC free article] [PubMed]
  • Orient W. Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease. New York: Free Press; 2004.
  • Parkhill J. Wren BW. Thomson NR. Titball RW, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 2001;413:523–527. [PubMed]
  • Perry RD. Fetherston JD. Yersinia pestis—etiologic agent of plague. Clin Microbiol Rev. 1997;10:35–66. [PMC free article] [PubMed]
  • Pollitzer R. Plague. Geneva: World Health Organization, Palais des Nations; 1954.
  • Protsenko OA. Anisimov PI. Mosarov OT. Donnov NP, et al. Detection and characterization of Yersinia pestis plasmids determining pesticin I, fraction 1 antigen and mouse toxin synthesis. Genetika. 1983;19:1081–1090. [PubMed]
  • Protsenko OA. Filippov AA. Kutyrev VV. Integration of the plasmid encoding the synthesis of capsular antigen and murine toxin into Yersinia pestis chromosome. Microb Pathogen. 1991;11:123–128. [PubMed]
  • Rosqvist R. Skurnik M. Wolf-Watz H. Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature. 1988;334:522–525. [PubMed]
  • Rudolph AE. Stuckey JA. Zhao Y. Matthews HR, et al. Expression, characterization, and mutagenesis of the Yersinia pestis murine toxin, a phospholipase D superfamily member. J Biol Chem. 1999;274:11824–11831. [PubMed]
  • Sebbane F. Devalckenaere A. Foulon J. Carniel E. Simonet M. Silencing and reactivation of urease in Yersinia pestis is determined by one G residue at a specific position in the ureD gene. Infect Immun. 2001;69:170–176. [PMC free article] [PubMed]
  • Simonet M. Riot B. Fortineau N. Berche P. Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infect Immun. 1996;64:375–379. [PMC free article] [PubMed]
  • Skurnik M. Peippo A. Ervelä E. Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b. Mol Microbiol. 2000;37:316–330. [PubMed]
  • Sodeinde OA. Subrahmanyam YVBK. Stark K. Quan T, et al. A surface protease and the invasive character of plague. Science. 1992;258:1004–1007. [PubMed]
  • Soupart P. Free amino acids of blood and urine in the human. In: Holden JT, editor. Amino Acid Pools. Amsterdam: Elsevier Publishing; 1962. pp. 220–262.
  • Suntsov V. Suntsova N. Concepts of macro- and microevolution as related to the problem of origin and global expansion of the plague pathogen Yersinia pestis. Biol Bull. 2008;35:333–338. [PubMed]
  • Surgalla MJ. Andrews AW. Baugh CL. Effects of bicarbonate on growth of Pasteurella pestis. I. Differential response of virulent and avirulent cells. J Bacteriol. 1964;88:269–272. [PMC free article] [PubMed]
  • Thomson NR. Howard S. Wren BW. Holden MTG, et al. The complete genome sequence and comparative genome analysis of the high pathogenicity Yersinia enterocolitica strain 8081. PLoS Genet. 2006;2:e206. [PubMed]
  • Torosian SD. Zsigray RM. The ail locus of e EV76-51F is disrupted by IS285 insertions, abstr. B-213, p. 191. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology; Washington, DC: 1966.
  • Viola RE. Yerman L. Fowler JM. Arvidson CG. Brubaker RR. A missense mutation causes aspartase-deficiency in Yersinia pestis. Microbiology. 2008;154:1271–1280. [PubMed]
  • Winter CC. Cherry WB. Moody MD. An unusual strain of Pasteurella pestis isolated from a fatal case of human plague. Bull WHO. 1960;23:408–409. [PubMed]
  • Worsham PL. Roy C. Pestoides F, a Yersinia pestis strain lacking plasminogen activator, is virulent by the aerosol route. Adv Exp Med Biol. 2003;e:129–131. [PubMed]
  • Zahorchak RJ. Charnetzky WT. Little RV. Brubaker RR. Consequences of Ca2+ deficiency on macromolecular synthesis and adenylate energy charge in Yersinia pestis. J Bacteriol. 1979;39:792–799. [PMC free article] [PubMed]
  • Zhou D. Han Y. Song Y. Tong Z, et al. DNA microarray analysis of genome dynamics in Yersinia pestis: insights into bacterial genome microevolution and niche adaptation. J Bacteriol. 2004a;186:5138–5146. [PMC free article] [PubMed]
  • Zhou D. Tong Z. Song Y. Han Y, et al. Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol. 2004b;186:5147–5152. [PMC free article] [PubMed]
  • Zink DL. Feeley JC. Wells JG. Vanderzant C, et al. Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature. 1980;283:224–226. [PubMed]
Articles from Vector Borne and Zoonotic Diseases are provided here courtesy of
Mary Ann Liebert, Inc.